Literature DB >> 6196208

Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens.

N Flomenberg, K Naito, E Duffy, R W Knowles, R L Evans, B Dupont.   

Abstract

T cell clones were selected which were cytotoxic for human class I major histocompatibility target antigens. Specificity was based on target cell panel studies and inhibition by monoclonal antibodies to class I determinants. Eight clones were Leu 2+3-. The cytotoxicity of these clones was inhibited by antibody to the Leu 2 antigen. Two clones expressed the Leu 2-3+ phenotype and were not inhibited by anti-Leu 2a or anti-Leu 3a antibodies. These studies indicate that class I-specific cytotoxic T cells are distributed in both T cell subsets, though predominantly in the Leu 2+3- group. In addition, these studies suggest that the Leu 3 molecule may not function in identical fashion in Leu 3+ cytotoxic T cells, which recognize class I target antigens, as in those which recognize class II targets.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196208     DOI: 10.1002/eji.1830131109

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  T lymphocyte clones detecting novel supertypic HLA class II allospecificities.

Authors:  N Flomenberg; R W Knowles; D Williams; K Horibe; K Rosenkrantz; B Dupont
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 2.  T-cell clones and T-cell receptors.

Authors:  F W Fitch
Journal:  Microbiol Rev       Date:  1986-03

3.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  HLA class I specific T lymphocyte clones with dual alloreactive functions.

Authors:  N Flomenberg; C Russo; S Ferrone; B Dupont
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells.

Authors:  J P DiSanto; J S Klein; N Flomenberg
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.

Authors:  A Belldegrun; A Kasid; M Uppenkamp; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.

Authors:  J A Gracie; E M Bolton; C Porteous; J A Bradley
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

9.  A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells.

Authors:  H Yssel; H Spits; J E de Vries
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.